61. NEUROLEPTIC MALIGNANT SYNDROME neuroleptic malignant syndrome OR NMS. This catastrophic reaction to dopamineblocking agents, especially HALDOL, more recently RESPIRADOL, http://www.idiom.com/~drjohn/nms.html

NEUROLEPTIC MALIGNANT SYNDROME OR NMS This catastrophic reaction to dopamine blocking agents, especially HALDOL, more recently RESPIRADOL, (but all the so-called major tranquilizers have been implicated) can lead to death in up to 50% of cases, especially if not immediately recognized. The causative agents must be stopped immediately and never started again. Three Principal Indicators Extreme muscle rigidity - one patient had to have a tenosynovotomy of her Achilles tendons (heel cords cut). Extreme autonomic instability especially rapid heart rate (over 100), temperatures up to 108 (at which point the brain's proteins denature like the white of an egg and there's no return), sweating, high blood pressure (sometimes over 200 systolic), incontinence. Pulmonary emboli may occur. Extreme mental status changes including restlessness, delirium, stupor and coma although patient may be conscious and "locked in." Often mistaken for catatonic schizophrenia (another imaginary "disease of the mind") and treated with even more of the hair of the dog, the anti-psychotic medications and even with electroconvulsive therapy (ECT)!

62. NEUROLEPTIC MALIGNANT SYNDROME As stated in a The neuroleptic malignant syndrome and Related Conditions* Interest neuroleptic malignant syndromelike State Following a Withdrawal of http://www.idiom.com/~drjohn/biblio.html

NEUROLOGIC MALIGNANT SYNDROME (NMS) A CHRONOLOGICAL ANNOTATED BIBLIOGRAPHY prepared by John M. Friedberg, MD February 5, 1997 Case reports of NMS and literature reviews were readily available in both psychiatric and neurologic journals from 1956, a few years after the introduction of the first phenothiazine, Chlorpromazine (Thorazine). As this chronology shows, there was a flurry of reports throughout the decade of the 1970's. As stated in a The Neuroleptic Malignant Syndrome and Related Conditions*: "Interest and increased awareness in febrile catatonic states associated with neuroleptic administration was quite evident by the mid 1970's. At this time, NMS had been fairly well reported in France, Japan and England. Several American authors cognizant of the French reports, also began to use the term neuroleptic malignant syndrome to describe similar cases in the United States." (p 5) The French were the first to observe the artificial hibernation produced by the anti-histamine related group of drugs called phenothiazines and the first to apply this observation for human behavioral control. It is not surprising that the very term Neurologic Malignant Syndrome is a translation of the French term "syndrome malin des neuroleptiques." Despite the recent obfuscation (e.g. in the book cited above) of NMS and "Lethal Catatonia of Stauder," the epidemic of NMS which followed the epidemic of neuroleptics in the 1860's was clearly a new and alarming phenomenon.

63. Neuroleptic Malignant-like Syndrome Due To Herbicide Intoxication neuroleptic malignant syndrome associated with amoxapine and lithium in an older Acute basagran poisoning mimicking neuroleptic malignant syndrome. http://med.ege.edu.tr/norolbil/2005/NBD33804.htm

64. WorstPills.org - Search Results For Neuroleptic Malignant Syndrome Search Results for neuroleptic malignant syndrome. http://www.worstpills.org/results.cfm?druginduced_id=382

65. IngentaConnect Neuroleptic Malignant Syndrome Induced By Atypical Antipsychotics neuroleptic malignant syndrome induced by atypical antipsychotics A reviewof the English literature confirms that neuroleptic malignant syndrome (NMS) http://www.ingentaconnect.com/content/apl/eds/2003/00000002/00000001/art00003

Home About Ingenta Ingenta Labs Help For Publishers Why go online? Why choose IngentaConnect? Why choose CustomConnect? Access and authentication ... Contact us For Researchers About IngentaConnect Search and browse Publications available Accessing articles ... Register For Librarians Why choose IngentaConnect? Why choose IngentaConnect Premium? Activating Subscriptions Purchasing articles ... Browse Publications Neuroleptic malignant syndrome induced by atypical antipsychotics Author: Farver D.K. Source: Expert Opinion on Drug Safety , Volume 2, Number 1, 1 January 2003, pp. 21-35(15) Publisher: Ashley Publications View Table of Contents full text options Abstract: A review of the English literature confirms that neuroleptic malignant syndrome (NMS) occurs with both traditional and atypical antipsychotic medications. Published reports of NMS induced by the traditional antipsychotics have given the practitioner valuable information on the prevention and treatment of this adverse effect. Case reports have also been published concerning NMS and clozapine, risperidone, olanzapine and quetiapine. By evaluating the case reports of atypical antipsychotic-induced NMS, valuable information may be obtained concerning similarities or differences from that induced by the traditional antipsychotics. The case reports of NMS with atypical antipsychotics were evaluated for diagnosis, age/sex of patient, risk factors, antipsychotic doses and duration of use, symptoms of NMS, and clinical course.

66. Neuroleptic Malignant Syndrome (a Case Report). Patkar AA, Shah LP J Postgrad Me J Postgrad Med, Online version this peerreviewed periodical, a publication ofthe Staff Society of Seth GS Medical College and KEM Hospital, India, http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1991;volume=37;issue=3

67. Neuroleptic Malignant Syndrome (a Case Report).,Patkar AA, Shah LP: J Postgrad M Indexed peerreviewed biomedical periodical of Staff Society of Seth GS MedicalCollege and KEM Hospital, India, with free access to full-text since 1990. http://www.jpgmonline.com/article.asp?issn=0022-3859;year=1991;volume=37;issue=3

68. THE MERCK MANUAL--SECOND HOME EDITION, Schizophrenia In Ch. 107, Schizophrenia A What Is neuroleptic malignant syndrome? neuroleptic malignant syndrome is a stateof unresponsiveness caused by use of certain antipsychotic drugs. http://www.merck.com/mmhe/sec07/ch107/ch107b.html

var externalLinkWarning = "The link you have selected will take you to a site outside Merck and The Merck Manuals.*n*nThe Merck Manuals do not review or control the content of any non-Merck site. The Merck Manuals do not endorse and are not responsible for the accuracy, content, practices, or standards of any non-Merck sources."; Search The Second Home Edition , Online Version Search Index A B C D ... Z Sections Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders ... Women's Health Issues Resources Anatomical Drawings Multimedia Pronunciations Weights and Measures ... , Online Version Section Mental Health Disorders Chapter Schizophrenia and Delusional Disorder Topics Introduction Delusional Disorder Schizophrenia Schizophrenia Buy The Book Print This Topic Email This Topic Pronunciations amphetamines anhedonia bromocriptine chlorpromazine ... triglycerides Schizophrenia is a mental disorder characterized by loss of contact with reality (psychosis), hallucinations (usually, hearing voices), delusions (false beliefs), abnormal thinking, flattened affect (restricted range of emotions), diminished motivation, and disturbed work and social functioning. Schizophrenia is a major health problem throughout the world. The disorder typically strikes young people at the very time they are establishing their independence and can result in lifelong disability and stigma. In terms of personal and economic costs, schizophrenia has been described as among the worst disorders afflicting humankind.

69. Neuroleptic Malignant Syndrome Lawsuit Overview - Find Trial Lawyers And Attorne neuroleptic malignant syndrome Overview - Find Trial Lawyers and Attorneys withExperience in neuroleptic malignant syndrome Personal Injury Law. http://www.injuryboard.com/view.cfm/Topic=621

t = location.href.split('?'); qs = (t[1] != null)?t[1]:'t=0'; document.writeln(""); Advertise On InjuryBoard.com September 9, 2005 More than 3 million people worldwide fly on a commercial aircraft everyday. Personal Injury Guidant Defibrillator Recall Vioxx / Rofecoxib Celebrex / Celecoxib ... Injuries Neuroleptic Malignant Syndrome Overview If you or a family member has been injured, contact a personal injury attorney today. Just fill out InjuryBoard.com's on-line questionnaire and have a personal injury lawyer review your potential personal injury claim - free of charge. Ask an Attorney Neuroleptic Malignant Syndrome (NMS) is a potentially fatal complex that is associated with the use of nearly all antipsychotic drugs. Symptoms of NMS include, but are not limited to, acute kidney failure , body temperature in excess of 106 degrees (hyperpyrexia), rigid muscles, irregular pulse or blood pressure , rapid heart beat ( tachycardia ), and irregular heartbeat.

70. HighWire -- Browse Journals - Neuroleptic Malignant Syndrome Browse Journals publishing on neuroleptic malignant syndrome Journals focusingon neuroleptic malignant syndrome (in order by highest focus) http://highwire.stanford.edu/lists/topic_dir/608683/618131/620438/620470/620471/

ANNOUNCEMENT: CHECK OUT THE PREVIEW RELEASE OF OUR NEW WEB SITE! My Favorite Journals ( HW-hosted journals HW-hosted Medline Author: Keyword(s): Year: Vol: Page: Home Adv. Search For Institutions For Publishers ... Sign in or register for access to all HighWire Press customization features Browse Journals publishing on Neuroleptic Malignant Syndrome: (return to Topic List page) Neuroleptic Malignant Syndrome Sort by: Alphabet Frequency of articles in Neuroleptic Malignant Syndrome Focus of journal on Neuroleptic Malignant Syndrome What's this? Journals focusing on Neuroleptic Malignant Syndrome (in order by highest focus) American Journal of Psychiatry info free ISSUES The British Journal of Psychiatry ... Neurotoxicity Syndromes Neuroleptic Malignant Syndrome Home Adv. Search For Institutions For Publishers ... partners/suppliers

71. Neuroleptic Malignant Syndrome neuroleptic malignant syndrome drug treatment. Browsing results for NeurolepticMalignant Syndrome. A B C D E F G H I J K L M N O P Q R S T U V W X Y Z http://browse.drugs.com/cond-neuroleptic_malignant_syndrome.html

Advanced Search Or click the first letter of a drug name: A B C D ... Z Browsing results for Neuroleptic Malignant Syndrome A B C D ... Z Definition: This describes the combination of catatonic rigidity, stupor, unstable blood pressure, fever, profuse sweating, sweating and incontinence as a reaction to antipsychotic agents (phenothiazines) in therapeutic doses. Drugs related to Neuroleptic Malignant Syndrome Atamet (consumer information) carbidopa (consumer information) carbidopa and levodopa (consumer information) Lodosyn (consumer information) Parcopa (consumer information) Parcopa Orally Disintegrating Tablets (professional information) Sinemet (consumer information) Sinemet CR (consumer information) Home Drug Interactions Pill Identification Question.com ... About Drugs.com The drugs.com drug database is powered by Micromedex TM and Multum TM Micromedex data last updated 5 August 2005. Micromedex Physicians Desk Reference data last updated 18 July 2005. Multum data last updated 15 August 2005. We subscribe to the HONcode principles. Verify here Most Popular Drug Searches: Abilify Acetaminophen Aciphex Adderall ... Forum Drugs.com - prescription drug and medicine information available on over 24,000 approved-

72. Arch Intern Med -- Abstract: The Neuroleptic Malignant Syndrome, June 1, 1982, S The neuroleptic malignant syndrome. RA Smego Jr and DT Durack. The neurolepticmalignant syndrome (NMS) comprises hyperpyrexia, altered consciousness, http://archinte.ama-assn.org/cgi/content/abstract/142/6/1183

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress Vol. 142 No. 6, June 1, 1982 Featured Link E-mail Alerts ARTICLE Article Options Send to a Friend Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Smego RA Durack DT Articles that cite this article Contact me when this article is cited The neuroleptic malignant syndrome R. A. Smego Jr and D. T. Durack The neuroleptic malignant syndrome (NMS) comprises hyperpyrexia, altered consciousness, muscular rigidity, and autonomic dysfunction. It is a rare idiosyncratic reaction to major tranquilizers, including the phenothiazines, butyrophenones, and thioxanthenes; haloperidol and fluphenazine enanthate or fluphenazine decanoate are the drugs most commonly incriminated. The syndrome occurs after therapeutic rather than toxic doses of neuroleptic drugs and is unrelated to the duration of therapy. The NMS is attributed to a disturbance of dopaminergic systems

73. Arch Intern Med -- Abstract: Metoclopramide-induced Neuroleptic Malignant Syndro The neuroleptic malignant syndrome (NMS), an unusual idiosyncratic reaction toneuroleptic medications, may be fatal if unrecognized. http://archinte.ama-assn.org/cgi/content/abstract/147/8/1495

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress Vol. 147 No. 8, August 1, 1987 Featured Link E-mail Alerts ARTICLE Article Options Send to a Friend Similar articles in this journal Literature Track Add to File Drawer Download to Citation Manager PubMed citation Articles in PubMed by Friedman LS D'Elia JA Articles that cite this article Contact me when this article is cited Metoclopramide-induced neuroleptic malignant syndrome L. S. Friedman, L. A. Weinrauch and J. A. D'Elia The neuroleptic malignant syndrome (NMS), an unusual idiosyncratic reaction to neuroleptic medications, may be fatal if unrecognized. Symptoms of NMS include rigidity, hyperpyrexia, altered consciousness, and autonomic instability. This syndrome is generally associated with neuroleptic medications used to treat psychotic and major depressive illnesses. We describe two diabetic patients at our institution who developed NMS in association with antiemetic metoclopramide hydrochloride.

74. Neuroleptic Malignant Syndrome: Case Report And Review -- Dykstra And Menolasino neuroleptic malignant syndrome is a rare but potentially fatal disorder that Because neuroleptic malignant syndrome is rare, clinicians often have a low http://www.jaoa.org/cgi/content/abstract/97/6/355

HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Download to citation manager PubMed PubMed Citation Articles by Dykstra, T. Articles by Menolasino MJ, , 3rd Journal of the American Osteopathic Association, Vol 97, Issue 6, 355-355 Case Reports Neuroleptic malignant syndrome: case report and review TJ Dykstra and Menolasino MJ 3rd Neuroleptic malignant syndrome is a rare but potentially fatal disorder that has been associated with the use of antipsychotic medications. Because neuroleptic malignant syndrome is rare, clinicians often have a low index of suspicion for the disorder which may lead to delayed treatment and increased mortality. This article describes a case of neuroleptic malignant syndrome and briefly reviews current diagnostic criteria and treatment options. HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS

75. Neuroleptic Malignant Syndrome In The Intensive Care Unit -- Sing Et Al. 93 (5): After administration of this drug, neuroleptic malignant syndrome developed.The authors review the literature as it relates to the use of haloperidol and http://www.jaoa.org/cgi/content/abstract/93/5/615

HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Download to citation manager PubMed PubMed Citation Articles by Sing, R. Articles by Marino, P. Journal of the American Osteopathic Association, Vol 93, Issue 5, 615-615 Case Reports Neuroleptic malignant syndrome in the intensive care unit RF Sing, CC Branas, and PL Marino The authors describe the postoperative course of a 43-year-old man. Haloperidol was administered for agitation while the patient was in the intensive care unit. After administration of this drug, neuroleptic malignant syndrome developed. The authors review the literature as it relates to the use of haloperidol and the associated adverse effect of neuroleptic malignant syndrome. This report of a case demonstrating haloperidol's potential toxicity is intended to increase awareness within the critical care community and thereby prompt early diagnosis and aggressive management to prevent haloperidol-associated morbidity and mortality. HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS

76. Myoglobinuria; Rhabdomyolysis neuroleptic malignant syndrome Other Occasional myoglobinuria Serum CK Maybe high but lower than neuroleptic malignant syndrome; Leukocytosis http://www.neuro.wustl.edu/neuromuscular/msys/myoglob.html

Front Search Index Links ... Patient Info MYOGLOBINURIA - RHABDOMYOLYSIS Myoglobinuria Malignant hyperthermia General features Pathophysiology Specific causes Myoglobinuria: Acquired causes Compartment syndromes Drugs Hypokalemia Idiopathic recurrent ... Other: Occasional myoglobinuria Polymyositis: Anti-MAS syndrome Serotonin syndrome Snake venoms Thyroid: Hyper or Hypo Toxins Trauma Myoglobinuria: Familial causes ... Malignant hyperthermia (MHS) loci : Ryanodine Receptor; 19q13 : Na channel (SCNA4); 17q11 : Ca channel (CACNL2A); 7q21 : Ca channel (CACNA1S); 1q32 Mitochondrial Myoadenylate deaminase deficiency Sickle cell anemia Other familial causes MYOGLOBINURIA: General features Myoglobinuria: General pathology Necrosis, especially acute, of muscle fibers (rhabdomyolysis) Release of muscle components into circulation Mechanisms of muscle injury Rise in free intracellular calcium: Due to Damage to muscle sarcolemma Failure of energy supply within muscle cell Destroys myofibrillar, cytoskeletal, and membrane proteins Lysosomal digestion of muscle fiber contents ensues Typical clinical features Muscle Discomfort: Pain; Tenderness

77. Neuroleptic Malignant Syndrome A Primary Care Perspective neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapythat can be missed if not suspected. This manuscript reviews the http://www.psychiatrist.com/pcc/abstracts/pcc060501.htm

78. The Bioline EPrints Archive - Neuroleptic Malignant Syndrome In Two Brothers Wit neuroleptic malignant syndrome (NMS) is a lifethreatening condition associated with Keywords, neuroleptic malignant syndrome, mental retardation http://bioline.utsc.utoronto.ca/archive/00002947/

@import url(http://bioline.utsc.utoronto.ca/eprints.css); @import url(http://bioline.utsc.utoronto.ca/eprints.css); @import url(http://bioline.utsc.utoronto.ca/print.css); The Bioline EPrints Archive Home About Browse Search ... Help Neuroleptic malignant syndrome in two brothers with mental retardation Altindag, Abdurrahman and Yanik, Medaim and Nebioglu, Melike Neuroleptic malignant syndrome in two brothers with mental retardation Klinik Psikofarmakoloji Bulteni / Bulletin of Clinical Psychopharmacology pp. 150-153 Full text available as: PDF - Requires Adobe Acrobat Reader or other PDF viewer. Abstract Antipsychotic drugs have been widely used in patients with mentalretardation. Neuroleptic malignant syndrome (NMS) is a life-threatening condition associated with dopaminergic blockage.Mentally retarded patients using intramuscular antipsychoticinjections have a significantly higher risk of developing NMS. In thispaper, NMS is reported in two brothers (ages 20 and 29) with mentalretardation. Both cases had clinical manifestations of NMS includingmuscle rigidity, hyperprexia, tremor, altered mental status, acuterenal failure, elevated creatinine phosphokinase levels andautonomic instability after 3 weeks of haloperidol treatment.Haloperidol was discontinued in both patients and supportivetreatment and bromocriptine was initiated. Clonazepam was alsostarted in one of the patients. While the younger patient who usedclonazepam was discharged from the hospital 20 days later, theolder one died due to cardiovascular collapse

79. The Journal Of Nervous And Mental Disease - UserLogin neuroleptic malignant syndrome and Related Conditions Mann, Stephan C., Caroff, This eminently useful source book on neuroleptic malignant syndrome, http://www.jonmd.com/pt/re/jnmd/fulltext.00005053-200401000-00026.htm

LWWOnline LOGIN eALERTS REGISTER ... Archive You are attempting to access protected content. To access this content please login using an established account or create/activate an account. If you have already created/ activated an online account, please login below: User Name: Password: Note: passwords are CASE SENSITIVE If you are a new user or guest visiting an LWWonline site for the first time, please complete the new account setup process to view or purchase content. Forgot your password? Subscribe Renewal Information Subscribe to RSS feed utrdc-pt02 Release 4.0

80. Blackwell Synergy - Cookie Absent Atypical neuroleptic malignant syndrome caused by olanzapine Objectiveneuroleptic malignant syndrome (NMS) is a rare syndrome with four main symptoms http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-0447.2005.00578.x

Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20